Abstract
Keywords:
atherosclerosis; brown adipose tissue; cardiovascular diseases; lipoprotein; triglyceride.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adipose Tissue, Brown / drug effects
-
Adipose Tissue, Brown / metabolism*
-
Adrenergic beta-3 Receptor Agonists / pharmacology*
-
Animals
-
Apolipoprotein E3 / genetics
-
Apolipoprotein E3 / metabolism*
-
Atherosclerosis / genetics
-
Atherosclerosis / metabolism
-
Atherosclerosis / pathology
-
Atherosclerosis / prevention & control*
-
Biomarkers / blood
-
Cholesterol Ester Transfer Proteins / genetics
-
Cholesterol Ester Transfer Proteins / metabolism*
-
Dioxoles / pharmacology*
-
Disease Models, Animal
-
Gene Knockdown Techniques*
-
Humans
-
Lipids / blood*
-
Lipolysis / drug effects
-
Liver / metabolism*
-
Mice
-
Mice, Inbred C57BL
-
Mice, Transgenic
-
Plaque, Atherosclerotic
-
RNA Interference
-
RNA, Small Interfering / genetics
-
RNA, Small Interfering / metabolism
-
Scavenger Receptors, Class B / deficiency*
-
Scavenger Receptors, Class B / genetics
Substances
-
Adrenergic beta-3 Receptor Agonists
-
Apolipoprotein E3
-
Biomarkers
-
CETP protein, human
-
Cholesterol Ester Transfer Proteins
-
Dioxoles
-
Lipids
-
RNA, Small Interfering
-
Scarb1 protein, mouse
-
Scavenger Receptors, Class B
-
disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate